Technology-assisted Rehabilitation After Acute Stroke
Primary Purpose
Stroke
Status
Unknown status
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
Technology-assisted rehabilitation
Conventional rehabilitation
Sponsored by

About this trial
This is an interventional treatment trial for Stroke
Eligibility Criteria
Inclusion Criteria:
- age 18 or more
- first stroke
Exclusion Criteria:
- unstable cardiopulmonary condition
- severe cognitive disorder
- aphasia
Sites / Locations
- VetreaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Technology-assisted rehabilitation
Conventional rehabilitation
Arm Description
Augmented exercise therapy with novel technology
Traditional multidisciplinary rehabilitation
Outcomes
Primary Outcome Measures
WHODAS 2.0
World Health Organization Disability Assessment Schedule - 12 questions scoring 1 to 5 yielding a total score from 12 to 60. A higher score means an increasing disability.
service use and costs
amount and costs of social and health care services used
Secondary Outcome Measures
PROMIS Global 10
Patient Reported Outcome Measurement Information System - a generic global health scale v1.2 consists of 10 questions across 6 health items. Two of the items (Physical and Mental) can be converted to T-scores allowing comparisons to a general population.
FAC
Functional Ambulation Categories - categorical scale ranging from 0 (unable to walk) to 5 (independent walking without assistive devices on any surfaces).
Hand grip force
hand grip
Shoulder elevation test
shoulder range of motion
Full Information
NCT ID
NCT04647812
First Posted
November 30, 2020
Last Updated
April 14, 2021
Sponsor
Vetrea Terveys Oy
Collaborators
Kuopio University Hospital, City of Kuopio
1. Study Identification
Unique Protocol Identification Number
NCT04647812
Brief Title
Technology-assisted Rehabilitation After Acute Stroke
Official Title
Technology-assisted Rehabilitation After Acute Stroke
Study Type
Interventional
2. Study Status
Record Verification Date
April 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 4, 2021 (Actual)
Primary Completion Date
August 2022 (Anticipated)
Study Completion Date
September 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vetrea Terveys Oy
Collaborators
Kuopio University Hospital, City of Kuopio
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the study is to evaluate the effects and costs of an intensified rehabilitation for stroke patients. Using novel technologies the patients will receive an augmented exercise therapy during the first weeks after stroke. The effects on restoration of functions as well as on the costs incurred from social and health care services will be assessed and compared to the conventional rehabilitation over 6 month follow-up.
Detailed Description
The intervention consists of technology-assisted multidisciplinary rehabilitation for 3 weeks followed by an 8-week period of supervised home-based telerehabilitation and a weekly group exercise in an outpatient clinic. The effects on mobility, upper extremity motor functions and activities of daily living will be assessed using FAC, hand grip force, shoulder elevation test, WHODAS 2.0 and PROMIS scales. The costs incurred from social and health care services over 6 months will be compared to the control group receiving conventional rehabilitation. Patients aged 18 or more with their first stroke and stable cardiopulmonary condition will be consecutively recruited first into the control group (n=20) and thereafter into the experimental group (n=20). Patients with a severe cognitive deficit or aphasia will be excluded.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Model Description
Consecutive cohort study
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Technology-assisted rehabilitation
Arm Type
Experimental
Arm Description
Augmented exercise therapy with novel technology
Arm Title
Conventional rehabilitation
Arm Type
Experimental
Arm Description
Traditional multidisciplinary rehabilitation
Intervention Type
Behavioral
Intervention Name(s)
Technology-assisted rehabilitation
Intervention Description
Augmented exercise therapy with novel technology and home-based telerehabilitation
Intervention Type
Behavioral
Intervention Name(s)
Conventional rehabilitation
Intervention Description
Traditional multidisciplinary in-patient rehabilitation
Primary Outcome Measure Information:
Title
WHODAS 2.0
Description
World Health Organization Disability Assessment Schedule - 12 questions scoring 1 to 5 yielding a total score from 12 to 60. A higher score means an increasing disability.
Time Frame
6 months
Title
service use and costs
Description
amount and costs of social and health care services used
Time Frame
6 months
Secondary Outcome Measure Information:
Title
PROMIS Global 10
Description
Patient Reported Outcome Measurement Information System - a generic global health scale v1.2 consists of 10 questions across 6 health items. Two of the items (Physical and Mental) can be converted to T-scores allowing comparisons to a general population.
Time Frame
6 months
Title
FAC
Description
Functional Ambulation Categories - categorical scale ranging from 0 (unable to walk) to 5 (independent walking without assistive devices on any surfaces).
Time Frame
6 months
Title
Hand grip force
Description
hand grip
Time Frame
6 months
Title
Shoulder elevation test
Description
shoulder range of motion
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age 18 or more
first stroke
Exclusion Criteria:
unstable cardiopulmonary condition
severe cognitive disorder
aphasia
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kauko Pitkänen, MD, PhD
Phone
0505965289
Ext
358
Email
kauko.pitkanen@vetrea.fi
First Name & Middle Initial & Last Name or Official Title & Degree
Laura Airaksinen
Phone
0407291908
Ext
358
Email
laura.airaksinen@vetrea.fi
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kauko Pitkänen, MD, PhD
Organizational Affiliation
Vetrea Terveys Oy
Official's Role
Study Director
Facility Information:
Facility Name
Vetrea
City
Kuopio
State/Province
North Savo
ZIP/Postal Code
71130
Country
Finland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kauko Pitkänen, PhD
Phone
+358505965289
Email
kauko.pitkanen@vetrea.fi
12. IPD Sharing Statement
Learn more about this trial
Technology-assisted Rehabilitation After Acute Stroke
We'll reach out to this number within 24 hrs